The recently published clinical case report study by the Buschard group demonstrated that the treatment with fenofibrate (160 mg daily) initiated seven days after T1DM diagnosis resulted in a fast decline of insulin dose and long-term insulin-independency [192]. The gene discussed is INS; the disease is type 1 diabetes mellitus.